Xi Li provided evidence that C5aR1 inhibition reprograms tumor-associated macrophages in two murine breast cancer models: one intrinsically sensitive to PARP inhibitors (T22) and the other resistant (T127). This evidence concerns the gene C5AR1 and breast carcinoma.